These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22338189)

  • 1. [Advances in treatment of mantle cell lymphoma- an in-depth coverage of 52nd ASH annual meeting].
    Yang S; Fan L; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):575-6. PubMed ID: 22338189
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and management of lymphoma.
    Abbott BL
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):30-2. PubMed ID: 16879767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mantle cell lymphoma in the era of targeted-therapy-in-depth report on American Society of Hematology 53rd annual meeting].
    Liang R; Shi YK; Han XH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):690-2. PubMed ID: 23134877
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussion.
    Czuczman MS; Leonard JP; Williams ME
    Clin Adv Hematol Oncol; 2010 Apr; 8(4):A1-14; quiz A15. PubMed ID: 20552750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highlights in mantle cell lymphoma from the 2020 American Society of Clinical Oncology Annual Meeting.
    Clin Adv Hematol Oncol; 2020 Aug; 18 Suppl 11(8):1-20. PubMed ID: 33843873
    [No Abstract]   [Full Text] [Related]  

  • 6. Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II.
    O'Connor O; Wright J; Moskowitz CH; Muzzy J; MacGregor-Cortelli B; Hamlin P; Straus D; Trehu E; Schenkein DP; Zelenetz AD
    J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S21-2. PubMed ID: 19791425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical roundtable monograph: Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussion.
    Czuczman MS; Leonard JP; Williams ME
    Clin Adv Hematol Oncol; 2010 Apr; 8(4 Suppl 8):1-14; quiz 2p following page 14. PubMed ID: 20539272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mantle cell lymphoma: biological insights and treatment advances.
    Leonard JP; Williams ME; Goy A; Grant S; Pfreundschuh M; Rosen ST; Sweetenham JW
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):267-77. PubMed ID: 19717376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in mantle-cell lymphoma.
    Martin P; Coleman M; Leonard JP
    J Clin Oncol; 2009 Feb; 27(4):481-3. PubMed ID: 19075257
    [No Abstract]   [Full Text] [Related]  

  • 10. Mantle cell lymphoma.
    Birgitta S
    Semin Cancer Biol; 2011 Nov; 21(5):291-2. PubMed ID: 22082693
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
    Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
    Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mantle cell lymphoma: established therapeutic options and future directions.
    Lenz G; Dreyling M; Hiddemann W
    Ann Hematol; 2004 Feb; 83(2):71-7. PubMed ID: 14669040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantle cell lymphoma in first complete remission.
    Laport GG
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1118-9. PubMed ID: 17697975
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.
    Dietrich S; Tielesch B; Rieger M; Nickelsen M; Pott C; Witzens-Harig M; Kneba M; Schmitz N; Ho AD; Dreger P
    Cancer; 2011 May; 117(9):1901-10. PubMed ID: 21509767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mantle cell lymphoma].
    Ogura M
    Rinsho Ketsueki; 2001 Apr; 42(4):281-7. PubMed ID: 11400298
    [No Abstract]   [Full Text] [Related]  

  • 16. Review: stem cell transplantation for mantle cell lymphoma: not yet the standard of care.
    Sweetenham JW
    Clin Adv Hematol Oncol; 2009 May; 7(5):323-4. PubMed ID: 19521321
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mantle cell lymphoma: management in 2011].
    Bonnet C; Caers J; De Prijck B; Hafraoui K; Beguin Y
    Rev Med Suisse; 2011 Aug; 7(306):1644-9. PubMed ID: 21972731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?
    Sweetenham JW
    Bone Marrow Transplant; 2001 Nov; 28(9):813-20. PubMed ID: 11781640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: blastic Mantle Cell Leukemia.
    Bilgir O; Bilgir F; Eliyatkin N; Calan M; Ercan IA; Isikyakar T; Sari F
    Transfus Apher Sci; 2011 Oct; 45(2):157-60. PubMed ID: 21855414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood or marrow transplantation for mantle cell lymphoma.
    Kasamon YL
    Curr Opin Oncol; 2007 Mar; 19(2):128-35. PubMed ID: 17272985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.